Affinity of carvedilol for recombinant human adrenoceptors

Pharmacology Reviews and Communications

Volumn 10, Issue 1, 1997, Pages 43-49

  Hieble, J Paul ^a   Naselsky, Diane P ^a   Arch, Jonathan R S ^a   Chapman, Helen ^a   Smith, Stephen A ^a   Poyser, Robert H ^a   Ruffolo Jr , Robert R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2B ADRENERGIC RECEPTOR; ALPHA 2C ADRENERGIC RECEPTOR; CARVEDILOL; COMPLEMENTARY DNA; RECOMBINANT RECEPTOR;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CHO CELL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DNA LIBRARY; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; HUMAN; HYPERTENSION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY;

EID: 0031412516     PISSN: 10288945     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Bristow, M. R., Larrabee, P., Minobe, W., Roden, R., Skerl, L., Klein, J., Handwerger, D., Prot, J. D. and Muller-Beckmann, B. (1992) "Receptor pharmacology of carvedilol in the human heart," J. Cardiovasc. Pharmacol, 19 (Suppl. 1), S68-S80.
2. 1D-adrenoceptor subtype mediating contraction in the rat aorta," FASEB J., 9, A105.
3. Bylund, D. B., Eikenberg, D. C., Hieble, J. P., Langer, S. Z., Lefkowitz, R. J., Minneman, K. P., Molinoff, P. B., Ruffolo, R. R., Jr. and Trendelenberg, U (1994) "Nomenclature of Adrenoceptors," Pharmacol. Rev., 46, 121-136.
4. 1-adrenergic receptor blocking properties of various doses of carvedilol in healthy humans," Clin Pharmacol. & Ther., 55, 329-337.
5. Hattori, Y., Nakaya, H., Endou, M., Nakao, Y. and Kanno, M. (1989) "Vascular effects of carvedilol, a new β-adrenoceptor antagonist with vasodilating properties, in isolated canine coronary artery," J. Cardiovasc. Pharmacol, 13, 572-579.
6. Hieble, J. P. (1991) Structure-activity relationsltips for activation and blockade of β-adrenoceptors. In: β- Adrenoceptors: Molecular Biology, Biochemistry and Pharmacology, R. R. Ruffolo, Jr. (ed.) (Karger, Basel), pp. 105-172.
7. 1-adrenoceptor nomenclature: Consensus Update. Pharmacol Rev., 47, 267-270.
8. 1C-adrenergic receptor," Biochem. Biophys Res. Comm., 195, 902-909
9. Hofferber, E., Jacobitz, P. and Armah, B. I. (1988) "Vasodilating β-receptor antagonists: Comparison of labetalol, carvedilol, dilevalol and brefanolol," Naunyn-Schmiedeberg's Arch. Pharmacol., 338 (Suppl), R65.
10. Kawada, T., Ishibashi, T., Nakazawa, M., Satoh, S. and Imai, S. (1990) "Adrenoceptor blocking activity and cardiohemodynamic effects of carvedilol in animals," J. Cardiovasc. Pharmacol., 16, 147-153.
11. 1D-adrenoceptor on rat aorta," Br. J Pharmacol., 114, 25P.
12. 1A-adrenoceptor mediating contractile responses to noradrenaline in the isolated caudal artery of rat," Br J. Pharmacol, 120, 819-826.
13. 1A-subtype," Mol. Pharmacol., 46, 414-422.
14. 3-adrenergic receptors: differential agonist activation of recombinant receptors in Chinese hamster ovary cells," Mol. Pharmacol., 42, 634-637.
15. Marullo, S., Emorine, L. J., Strosberg, A. D. and Delavier-Klutchko, C. (1990) "Selective binding of ligands to beta-1, beta-2 or chimeric beta-1 /beta-2-adrenergic receptors involves multiple subsites," EMBO J., 9(5), 1471-1476.
16. Monopoli, A., Forlani, A., Bevilacqua, M , Vago, T., Norbiato, G., Bertora, P., Bigliolo, P., Alamanni, F. and Ongini, E. (1989) "Interaction of selected vasodilating β-blockers with adrenergic receptors in human cardiovascular tissues," J. Cardiovasc. Pharmacol., 14, 114-120.
17. 1-adrenoceptors," Pharmacol. Comm., 6, 23-28.
18. Nichols, A. J., Gellai, M. and Ruffolo, R. R., Jr. (1991) "Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agents, carvedilol," Fundam. Clin. Pharmacol, 5, 25-38.
19. Nichols, A. J., Sulpizio, A. C., Ashton, D. J., Hieble, J P. and Ruffolo, R. R., Jr. (1989a) "In vitro pharmacological profile of the novel β-adrenoceptor antagonist and vasodilator, carvedilol," Pharmacology, 39, 327-336.
20. 1-adrenoceptors," Chirality, 1, 265-270.
21. Ohlstein, E. H., Douglas, S. A., Sung, C. P, Yue, T. L., Louden, C. and Arleth, A. (1993) "Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration and neointimal formation following vascular injury," Proc. Natl. Acad. Sci. USA, 90, 6189-6193.
22. Olsen, A. L., Gilbert, E. M., Renlund, D. G., Taylor, D. O., Yanowitz, F. D. and Bristow, M. R. (1995) "Carvedilol improves left-ventricular function and symptoms in chronic heart failure - A double blinded randomized study," J. Am Coll. Cardiol., 25, 1225-1231.
23. Patel, M. K., Chan, P., Betteridge, L. J., Schacter, M. and Sever, P. S. (1995) "Inhibition of human vascular smooth muscle cell proliferation by the novel multiple-action antihypertensive agent carvedilol," J. Cardiovasc Pharmacol., 25, 652-657.
24. Pauwels, P. J., Gommeren, W., van Lommen, G., Janssen, P. A. J. and Leysen, J. E. (1989) "The receptor binding profile of the new antihypertensive agent nebivolol and its stereoisomers compared with various β-adrenergic blockers," Mol. Pharmacol, 34, 843-851.
25. Piascik, M. T., Sparks, M. S. and Pruitt, T. A. (1992) "Effect of chloroethylclonidine on arterial blood pressure and heart rate in the conscious rat," J. Pharmacol. Exp. Ther., 262, 901-906.
26. 3-adrenergic receptor," Pharmacol. Comm., 6, 229-236.
27. Price, D. T., Lefkowitz, R. J., Caron, M. G., Berkowitz, D. and Schwinn, D. A. (1994) "Localization of mRNA for three distinct α-adrenergic physiology," Mol. Pharmacol., 45, 171-175.
28. 1B-adrenergic receptor," J. Biol Chem., 267, 21936-21945.
29. 2-adrenergic receptor," J. Biol. Chem , 268, 4625-4636.
30. 1D-subtype," Can. J. Physiol. Pharmacol., 72 (Suppl. 1), 323.
31. Sung, C. P., Arleth, A. J. and Ohlstein, E. H. (1994) "Carvedilol, a novel antihypertensive and vascular protective agent, inhibits mitogen-activated protein kinases in rat aortic smooth muscle cells," Atherosclerosis, 109, 194-195.
32. 2-adrenergic receptor increases its affinity for a family of β-receptor antagonist," J. Biol. Chem., 226, 15488-15492.
33. Tate, K. M., Briend-Sutren, M. M., Emorine, L. J., Delavier-Klutchko, C., Marullo, S. and Strosberg, A. D. (1991) "Expression of three human beta-adrenergic-receptor subtypes in transfected Chinese hamster ovary cells," Eur. J. Biochem., 196(2), 357-361.
34. Yoshikawa, T., Port, J. D., Asano, K., Chidiak, P., Bouvier, M., Dutcher, D., Roden, R. L., Minobe, W., Tremmel, K. D. and Bristow, M. R. (1996) "Cardiac adrenergic receptor effects of carvedilol," Eur. Heart J., 17(Suppl. B), 8-16.
35. Yue, T. L., McKenna, P. J., Gu, J. L., Cheng, H. Y., Ruffolo, R. R., Jr. and Feuerstein, G. (1993) "Carvedilol, a new antihypertensive agent, prevents lipid peroxidation and oxidative injury to endothelial cells," Hypertension, 22, 922-928.
36. Zhu, W. Z., Zhang, Y. and Han, C. D. (1997) "Characterization of subtype of alpha(1)-adrenoceptor mediating vasoconstriction in perfused rat hind-limb," Eur. J. Pharmacol., 329(1), 55-61.